Skip to content
Home/Companies/Pharma/Advanthera
Advanthera

Advanthera

Pharma·Spain·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Advanthera?

Advanthera is currently owned by Columbus Venture Partners through Columbus Life Sciences Fund IV (2023 vintage), since 2024.

Hand-verified · updated 2026-08-09

Columbus Venture Partners
Investor
Columbus Venture Partners
Columbus Life Sciences Fund IV · 2023 · Life Sciences VC

Key facts

HQSpain
SectorPharma
StatusActive
Websiteadvanthera.com

More from Columbus Life Sciences Fund IV

Other portfolio companies in the same fund.

Accipiter Biosciences
Accipiter Biosciences
Active
BiotechUnited States· 2025
DeepUll
Active
HealthTechSpain· 2025
Quibim
Active
HealthTechSpain· 2025
Aleta Biotherapeutics
Aleta Biotherapeutics
Active
BiotechUnited States· 2024
Cocoon Bioscience
Cocoon Bioscience
Active
BiotechSpain· 2024
Curve Therapeutics
Curve Therapeutics
Active
BiotechUnited Kingdom· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Cinclus Pharma
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
InfoRLife
Active
BC PartnersSwitzerland· 2026
IRAB
IRAB
Active
ARCHIMEDSpain· 2026
Track Advanthera

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Advanthera.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue